Cahill represented the underwriters in connection with a secondary offering by IQVIA Holdings Inc. (NYSE IQV) of 5,000,000 shares of its common stock, publically priced at $141.00. IQVIA Holdings Inc. repurchased from the Underwriters 1,000,000 shares of the Common Stock that were sold by certain Selling Stockholders in the offering, at a per share purchase price of $140.80 which is equal to the per share purchase price paid by the Underwriters to the Selling Stockholders, resulting in an aggregate purchase price by IQVIA Holdings Inc. of $140,800,000.
IQVIA Holdings Inc. focuses on technology solutions and contract research services. The Company offers a broad range of solutions which includes clinical development strategies, therapeutic expertise, predictive and prescriptive analytics, and patient retention services.
Goldman Sachs & Co. LLC and Barclays acted as underwriters on the offering.
Cahill advised with a team including Stuart Downing (Picture), Alla Digilova, Michael Jiang, Frank N. Strumolo and Natasha N. Williams Goddard.
Involved fees earner: Alla Digilova – Cahill Gordon & Reindel; Stuart Downing – Cahill Gordon & Reindel; Michael Jiang – Cahill Gordon & Reindel; Frank Strumolo – Cahill Gordon & Reindel; Natasha Williams Goddard – Cahill Gordon & Reindel;
Law Firms: Cahill Gordon & Reindel;